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Abstract 
Several reports suggest the participation of
progesterone receptor membrane component
1 (PGRMC1) in progesterone signaling in the
reproductive  system.  This  study  aimed  at
investigating the presence and localization of
PGRMC1 in bovine ovary, oviduct and uterus,
during the follicular and luteal phases of the
estrous cycle. In the ovary, PGRMC1 has been
detected  in  surface  germinal  epithelium,
granulosa cells, theca cells and in the germi-
nal vesicle of the oocytes at all stages of fol-
liculogenesis.  In  the  corpus  luteum the
expression of PGRMC1 was influenced by the
stage of the estrous cycle. In the oviducts and
in the uterus horns, PGRMC1 was immunolo-
calized in the luminal epithelium, in the mus-
cle layer cells and in the endothelial cells. In
the uterus, PGRMC1 was intensely localized
also in the glandular endometrium. However,
in the oviducts and in the uterus horns, the
localization of PGRMC1 was independent on
the stage of the estrous cycle and on whether
evaluating the ipsilateral or the contralateral
organ. In conclusion, the present immunohis-
tochemical  study  showed  that  PGRMC1  is
located in various compartments of the bovine
female reproductive organs. With the excep-
tion of the corpora lutea, PGRMC1 localization
showed similar pattern during different stages
of the estrous cycle.
Introduction
Progesterone  receptor  membrane  compo-
nent 1 (PGRMC1) belongs to the membrane-
associated progesterone receptor (MAPR) pro-
teins family that is widespread in eukaryotes
and involved in regulating numerous biologi-
cal  functions.1 PGRMC1  is  predominantly
located  in  intracellular  membranes  and  co-
localizes with the endoplasmic reticulum and
Golgi apparatus in rat liver cells and hippocam-
pal Purkinje cells.2,3 Several studies described
a  nuclear  or  chromosomal  localization.
PGRMC1 was detected in nuclear extracts of
HeLa cells,4 among the protein of the human
mitotic spindles,5,6 and recently has been pro-
posed  in  regulating  microtubule  stability  in
human and rat ovarian cell mitosis.7,8 Various
ovarian  cell  types,  including  granulosa  cells
and ovarian surface epithelial cells as well as
ovarian  tumors,  express  PGRMC1  where  it
plays an essential role in promoting the sur-
vival  of  both  normal  and  cancerous  ovarian
cells in vitro.9
Recently,  PGRMC1  expression  has  been
demonstrated in several female reproductive
tissues  in  different  mammalian  species.
PGRMC1 has been detected in uterine and pla-
cental tissues of the mouse and human10 and it
is among the proteins that were differentially
expressed in the human endometrium during
menstrual cycle.11
Other reports investigated the localization
and function of PGRMC1 in the ovary. In partic-
ular  immunohistochemical  studies  localized
PGRMC1  in  granulosa  cells,  theca  cells  and
ovarian  surface  epithelial  cells  (germinal
epithelium) in rat.12 Moreover the expression
of PGRMC1 mRNA was found in granulosa or
luteal  cells  in  humans,13 mice,14 pigs15 and
cows.16 Several  works  suggest  that  proges-
terone  mediates  its  antiapoptotic  action
through  PGRMC1.17,18 PGRMC1  is  also
expressed  in  bovine,19  rat12 and  human
oocytes.20 Recently, PGRMC1 was associated to
the meiotic spindle suggesting a role in oocyte
maturation, which may be specifically related
to the mechanism by which chromosomes seg-
regate.19 However, with regard to localization
of the protein, a recent work did not detect
PGRMC1 in the bovine oocyte.21 To date there
is  little  information  on  the  localization  of
PGRMC1 in the reproductive organs of the cow.
Thus,  the  aim  of  the  present  study  was  to
examine  the  presence  and  localization  of
PGRMC1  in  a  variety  of  cow  reproductive
organs,  including  ovary,  oviduct  and  uterus
during the follicular and luteal phases of the
estrous cycle using immunohistochemistry.
Materials and Methods
Tissue collection
All the chemicals used in this study were
purchased  from  Sigma  Chemical  Company
except  for  those  specifically  mentioned.
Bovine ovary, oviduct and uterus were recov-
ered  at  a  local  abattoir  (INALCA  JBS  S.p.A.,
Ospedaletto Lodigiano, LO, IT 2270M CE, Italy)
from non-pregnant dairy cows, 4 to 8 yrs old,
subjected to routine veterinary inspection and
in accordance to the specific health require-
ments stated in Council Directive 89/556/ECC
and subsequent modifications, and were trans-
ported to the laboratory on ice. The stage of the
estrous cycle was assessed by morphological
observations of the ovary.22 In particular, ani-
mals in which one of the two ovaries present-
ed an active corpus luteum were classified as
belonging  to  luteal  phases  of  estrous  cycle
while animals in which one of the two ovaries
presented the ovulatory follicle and a regressed
corpus luteum were classified as belonging to
follicular phases of estrous cycle.23,24
For each animal, both ovaries were trans-
versely cut and 2-4 fragments of corpus luteum
and 2-4 fragments of ovarian cortex were col-
lected; from both oviducts samples of isthmus,
ampulla  and  infundibulum  were  separated.
Finally the apical third of each uterine horns
was isolated dissecting at about 5 cm from the
uterus-isthmic  junction.25 All  samples  were
fixed in B5 (Formalin-Mercury II Chloride) fix-
ative  (Bio-Optica,  Milan,  Italy)  for  12-24  h,
dehydrated  by  a  graded  series  of  ethanol,
cleared  with  xylene,  paraffin  embedded  and
sectioned at 5 µm on glass slides, previously
treated with Vectabond (Vector Laboratories,
Burlingame, CA, USA) to enhance the adher-
ence of tissue.
European Journal of Histochemistry 2011; volume 55:e27
Correspondence: Alberto M. Luciano, Sezione di
Anatomia ed Istologia Veterinaria, Dipartimento
di  Scienze  Animali,  Facoltà  di  Medicina
Veterinaria, Università degli Studi di Milano, via
Celoria 10, 20133 Milano, Italy. 
Tel. +39.02.50317969 – Fax: +39.02.50317980. 
E-mail: alberto.luciano@unimi.it
Key words: Uterus, oviduct, ovary, corpus luteum,
follicle, oocyte, progesterone receptor
Acknowledgements: the authors wish to thank Dr.
Nadia Fiandanese for her excellent technical support.
Contributions: DC, VL, IT, FF laboratory experi-
ments performing; AML, VL, SM results analysis
and interpretation; AML, VL, JJP, SM, research
theme defining, methods designing and manu-
script  writing.  All  authors  approved  the  manu-
script final version.
Received for publication: 28 July 2011.
Accepted for publication: 24 August 2011.
This work is licensed under a Creative Commons
Attribution NonCommercial 3.0 License (CC BY-
NC 3.0).
©Copyright A.M. Luciano et al., 2011
Licensee PAGEPress, Italy
European Journal of Histochemistry 2011; 55:e27
doi:10.4081/ejh.2011.e27
[European Journal of Histochemistry 2011; 55:e27] [page 145][page 146] [European Journal of Histochemistry 2011; 55:e27]
Western blot analysis
Western blot analysis was performed as pre-
viously described with minor modifications.19
Briefly, aliquots of 50 mg of ovarian cortex and
corpus  luteum were  homogenized  in  RIPA
buffer, which was supplemented with complete
protease and phosphatase inhibitor cocktails,
incubated  for  30  min  on  ice  and  then  cen-
trifuged at 14,000 g for 20 min at 4°C. Total
amount of protein was determined using the
Bio-Rad Protein Assay (Biorad) and 20 µg of
total protein was used for western blot analy-
sis.  Equal  protein  loading  was  verified  by
Ponceau staining. PGRMC1 immunodetection
was conducted using different concentrations
(1 µg/mL and 0.3 µg/mL) of a rabbit polyclonal
antibody (Sigma Prestige, Cat. No.HPA002877)
or a goat polyclonal antibody (AbCam, Cat. No.
ab48012)  overnight  at  4°C.  PGRMC1  was
revealed using an anti-rabbit or anti-goat HRP-
labelled antibodies (1:8000) and Super Signal®
West  Pico  Chemiluminescence  Substrate
(PIERCE  Biotechnologies  Inc.,  Rockford,  IL,
USA).  Negative  controls  were  conducted  by
omitting the primary antibodies.
Immunohistochemistry
Indirect immunohistochemistry was carried
out to evaluate the expression and localization
of  PGRMC1.  Endogenous  peroxidase  activity
was  eliminated  by  incubation  with  3%  (v/v)
H2O2 in methanol for 30 min. Then sections
were  incubated  with  10%  (v/v)  normal  goat
serum  or  normal  rabbit  serum,  0.3%  (v/v)
Triton X-100 and 3% (w/v) bovine serum albu-
min (BSA) in phosphate buffered saline (PBS)
for 30 min to block non-specific binding of sec-
ondary  antibody.  In  a  preliminary  study  the
sections were incubated overnight at 4°C with
different  concentrations  (0.96,  0.48,  0.24  or
0.16 µg/mL) of polyclonal rabbit anti-PGRMC1
(Sigma  Prestige)  or  polyclonal  goat  anti-
PGRMC1  (Abcam)  diluted  in  PBS  with  1%
(w/v) BSA and 0.3% (v/v) Triton X-100. In all
the subsequent experiments the rabbit poly-
clonal antibody was used at a concentration of
0.48 µg/mL. Primary antibodies were detected
by using a biotinylated anti-rabbit or anti goat
IgG (Vector Laboratories), diluted 1:400 in PBS
with 1% (w/v) of BSA and detected with the
Vectastain Elite ABC kit (Vectastain Elite ABC
kit,  Vector  Laboratories).  For  color  develop-
ment, all sections were incubated with DAB
substrate (DAB substrate kit for peroxidase,
Vector Laboratories) for 2 min. After staining,
the samples were counterstained with hema-
toxylin  QS  (Vector  Laboratories).  Negative
controls were performed by omitting the pri-
mary antibodies. Samples were analyzed on a
Nikon Eclipse microscope (Nikon Corp., Tokyo,
Japan)  in  bright  field  at  a  magnification  of
200X-400X.
Results
Preliminary studies were conducted in order
to compare the specificity and the sensitivity
of  two  antibodies  (polyclonal  rabbit  anti-
PGRMC1 and polyclonal goat anti-PGRMC1) by
western blot and immunohistochemical analy-
sis with different primary antibodies concen-
trations. Western blot analysis confirmed that
PGRMC1 was specifically detected in ovarian
cortex  as  a  ≈26  kDa  protein  (Figure  1A).
However,  only  the  polyclonal  rabbit  anti-
PGRMC1 detected the protein, while under the
same experimental conditions the goat poly-
clonal antibody did not. Conversely, the goat
polyclonal antibody only detected the 26 kDa
protein when higher amounts of total proteins
(100 and 50 µg) were loaded on the gel (Figure
1B). Moreover, antibody titration on immuno-
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Table 1. Immunohistochemical localization of PGRMC1 in the reproductive tracts dur-
ing estrous cycle. PGRMC1 is indicated as intense (+) weak (±) or negative signal in the
different organs.
Estrous cycle
Follicular phase Luteal phase
Tissue/cell type Cytoplasm Nucleus Cytoplasm Nucleus
Ovary follicle
Oocyte ±+ ±+
Granulosa cells ++ ++
Theca cells ++ ++
Endothelial cells ++ ++
Stromal tissue
Stromal cells ±± ±±
Endothelial cells ++ ++
Germinal epithelium ++ ++
Corpus luteum
Luteal cells ±± +±
Endothelial cells ++ ++
Oviduct
Epithelial cells ++ ++
Stromal cells ±± ±±
Muscle layer cells ++ ++
Endothelial cells ++ ++
Uterus
Luminal epithelial cells ++ ++
Glandular epithielial cells ++ ++
Stromal cells ±± ±±
Muscle layer cells ++ ++
Endothelial cells ++ ++
Figure  1.  Detection  of
PGRMC1  in  bovine  ovarian
cortex  and  corpus  luteum by
western  blot  analysis.  A)
Western blot analysis showing
PGRMC1 expression in bovine
ovarian  cortex  and  corpus
luteum  (20  µg  total  protein/
lane)  using  the  rabbit  poly-
clonal (Sigma-Prestige) or the
goat polyclonal (Abcam) anti-
bodies  at  different  concentra-
tions. Note that only the rabbit
polyclonal anti-PGRMC1 anti-
body  detected  the  protein,
while  under  the  same  experi-
mental  conditions  the  goat
polyclonal  antibody  did  not.
B)  Western  blot  analysis  of
PGRMC1 expression in ovari-
an cortex with the goat poly-
clonal antibody using increas-
ing amount of total protein (50
and 100 µg). [European Journal of Histochemistry 2011; 55:e27] [page 147]
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Figure 2. Titrations of different primary antibodies
to detect PGRMC1. A) Representative images of
PGRMC1 localization in a medium antral follicle
wall using rabbit polyclonal and goat polyclonal
primary antibodies. The values on the left refer to
the concentrations (µg/mL) of the primary anti-
bodies used. Note that rabbit polyclonal antibody
shows a specific staining for PGRMC1 in the gran-
ulosa cells, in the theca layer and in the endothelial
cells of blood vessels at all concentration used, whereas weaker signal was detected by the goat polyclonal antibody under the same experimen-
tal conditions. No immunoreactivity was seen in negative controls where incubation with the primary antibodies was omitted. Final magnifi-
cation, 200X; scale bar, 50 µm. B) Representative images showing details of PGRMC1 localization in oocytes and medium antral follicle wall
using the two antibodies under the same experimental conditions at a concentration of 0.48 µg/mL. Note that rabbit polyclonal primary anti-
body exhibits a specific staining for PGRMC1 in cumulus cells, germinal vesicle, granulosa cells, theca layer and endothelial cells (upper
images) when compared with the goat polyclonal primary antibody (lower images). Final magnification, 400X; scale bar, 50 µm.
AB[page 148] [European Journal of Histochemistry 2011; 55:e27]
histochemistry showed a higher sensitivity of
the polyclonal rabbit anti-PGRMC1 since this
antibody detected PGRMC1 in the granulosa
cells, in the theca layer and in the endothelial
cells of blood vessels at all concentration test-
ed,  whereas  the  goat  polyclonal  antibody
detected a much weaker signal at the corre-
sponding concentration (Figure 2A,B). In addi-
tion  the  rabbit  polyclonal  detected  a  much
higher PGRMC1 signal in cumulus cells and
germinal vesicle of the oocyte when compared
with the goat polyclonal used at the same con-
centration  (Figure  2B).  Therefore,  the  poly-
clonal rabbit anti-PGRMC1 antibody, at a con-
centration of 0.48 µg/mL was utilized in further
experiments to assess PGRMC1 localization in
bovine ovary, oviduct and uterine horn.
A total of 8 animals (4 for each phase of the
estrous  cycle)  were  analyzed  for  PGRMC1
localization. Data are shown in Figures 3, 4
and 5 and summarized in Table 1.
In all experiments, negative controls were
conducted in the absence of the primary anti-
body and did not show any staining.
In the ovary, immunohistochemical studies
showed that PGRMC1 was expressed in the fol-
licles during all the stages of folliculogenesis,
in the oocyte and in its surrounding cumulus
cells, both in the nucleus and inside the cyto-
plasm  (Figure  3).  Oocyte  showed  a  positive
staining in the germinal vesicle (GV), while
the  ooplasm  displayed  only  a  weak  signal
(Figure 3A,B). In the cumulus oophorus, gran-
ulosa cells lying closer to the oocyte exhibited
a more intense signal than granulosa cells in
the outer layers (Figure 2B). PGRMC1 was also
detected  in  theca  layers  (Figure  3C).
Furthermore,  PGRMC1  was  immunolocalized
in the germinal epithelium of the ovarian sur-
face (Figure 3D) and in the endothelial cells of
the stromal vessels (arrows in Figure 3A,B,C).
On the contrary, in ovarian stromal tissue cells
PGRMC1  was  weakly  detected.  Immunolo  -
calization  of  PGRMC1  revealed  a  similar
expression pattern for the follicular and luteal
phase of the estrous cycle and differences were
not observed between the two ovaries of the
same animal.
In contrast, in the corpus luteumPGRMC1 was
differently  immunolocalized  depending  on  the
stage of the estrous cycle (Figure 4). During the
luteal phase (Figure 4A) most of the luteal cells
showed a cytoplasmic staining for PGRMC1, with
signal intensity varying from intense to weak,
while the signal was completely absent only in a
few cells.  During the follicular phase (Figure 4B)
PGRMC1 was detected as a weak signal in the
cytoplasm of most of the cells. In both phases
PGRMC1 was expressed in the endothelial cells
and was detected as an intense to weak signal in
the nuclei of the luteal cells. 
Microscopic examination of PGRMC1 local-
ization  in  the  oviduct  revealed  a  specific
nuclear and cytoplasmic staining for PGRMC1
in the luminal epithelium (Figure 5A,B), in the
muscle layers (Figure 5C), as well as in the
endothelial cells. On the contrary PGRMC1 was
weakly expressed in the cells of lamina propria
and submucosa (stromal cells). No differences
were observed between infundibulum (Figure
5A), ampulla (Figure 5B), and isthmus (Figure
5C),  neither  in  follicular  nor  luteal  phase,
either between the two organs of the same ani-
mal. In the uterus, PGRMC1 was observed as
an intense signal in the luminal epithelium
(Figure 5E), glandular endometrium (Figure
5F), as well in the muscle layers (Figure 5F)
and in the vessels while a weak signal was
present in the stromal compartment. As in the
oviduct, a positive staining was present both in
the nucleus and in the cytoplasm of all the cells
and no difference was observed between the
estrous stages and between the two horns.
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Figure 3. Immunohistochemical localization of PGRMC1 in bovine ovarian cortex. PGRMC1
is localized in primordial, primary and secondary follicles (A), in early antral follicles (B) and in
antral follicles (C). Note that the expression of PGRMC1 is more evident in the granulosa cells
closer to the oocyte, in the GV and in the internal theca layer. PGRMC1 was detected in the
endothelial cells (arrows) and in the germinal epithelium at the ovarian surface (D, arrowhead).
No immunoreactivity was seen in negative control where incubation with the primary antibody
had been omitted (E).  Final magnification, 200X; scale bar, 50 µm.
Figure 4. Immunohistochemical localization of PGRMC1 in bovine corpora lutea during the
luteal and follicular phase of the estrous cycle. During the luteal phase (A) PGRMC1 is local-
ized in the cytoplasm of the luteal cells displaying an heterogeneous signal, varying from intense
to weak to completely absent. During the follicular phase (B) PGRMC1 is detected as a weak
signal in the cytoplasm of most of the luteal cells. In both phases PGRMC1 is expressed in the
endothelial cells and is weakly detected in the nucleus of the luteal cells. Final magnification,
200X; scale bar, 50 µm.[European Journal of Histochemistry 2011; 55:e27] [page 149]
Discussion
To the best of our knowledge, this is the first
study that describes PGRMC1 immunolocaliza-
tion in various parts of bovine reproductive sys-
tem. In the ovary, PGRMC1 has been detected in
germinal  epithelium,  granulosa  cells,  theca
cells, and oocyte in all stages of folliculogenesis,
in agreement with previous studies conducted
in rat.12Data from the literature indicate that, in
the ovary, PGRMC1 is continuously and highly
expressed during fetal development in rat and
cow and it has been suggested that PGRMC1
participates through a progesterone-dependent
mechanism to the process of primordial follicle
assembly.26,27
In this study, PGRMC1 was intensely localized
in the GV of oocytes. This confirms our previous
immunofluorescence study on the oocyte where
PGRMC1 was restricted in the GV after follicle
isolation.19 In the oocyte, PGRMC1 has a role in
oocyte  maturation,  which  may  be  specifically
related to the mechanism of chromosomes seg-
regation.19 However, other Authors were unable
to detect PGRMC1 in the bovine oocyte,21while it
was detectedin the surrounding granulosa cells.
This difference may be due to the different sen-
sitivity of the antibody used and to the shorter
incubation time employed in the previous study
(3 h). As indicated in our study, the polyclonal
rabbit anti-PGRMC1 antibody showed a much
higher sensitivity respect to the polyclonal goat
anti-PGRMC1 antibody and the titration assay
demonstrated that only high concentrations of
the polyclonal goat anti-PGRMC1 antibody were
able to detect a specific signal by western blot
and  immunohistochemistry  under  our  experi-
mental conditions.
Our  observations  in  the  ovary  and  corpus
luteum support  previous  studies  where  the
expression of PGRMC1 was found in granulosa
and luteal cells in human,13 mouse,14 rat,12 pig15
and cow.16,28 PGRMC1 positivity in endothelial
cells of the corpus luteum reported in previous
study on PGRMC1 expression in cow28 was also
confirmed by our observations. Furthermore, in
the present work, the expression of PGRMC1 in
the corpus luteumwas found to be influenced by
the  stage  of  the  estrous  cycle.  In  the  luteal
phase, PGRMC1 was intensely localized in the
cytoplasm while in the follicular phase a weak
PGRMC1 signal was detected in the cytoplasm of
most of the cells. This stage-specific localization
of PGRMC1 could be explained through the func-
tional status of the corpus luteum. Beside its
possible involvement in steroid synthesis in the
active corpus luteum, the ability of PGRMC1 in
promoting luteal cell viability by mediating prog-
esterone anti-apoptotic action was demonstrat-
ed.13
PGRMC1  was  detected  among  the  proteins
that were differentially expressed in the human
endometrium during the menstrual cycle.11 This
study showed that PGRMC1 protein was more
highly present in the proliferative (luteal) than
the secretory (follicular) phase and immunos-
taining data revealed that it was confined to the
stromal  component  of  proliferative  phase
endometrium. Analogously, microarray profiling
of  progesterone-regulated  endometrial  genes
during  the  rhesus  monkey  secretory  phase
showed a down regulation of PGRMC1.29 These
findings were confirmed also in mice,10 where
PGRMC1  expression  was  up-regulated  in  the
stromal compartment of the uterus from estrus
to metestrus and reduced during diestrus. In the
bovine, our study showed that PGRMC1 localiza-
tion in the oviducts and in the uterus horns, was
similar  in  the  ipsilateral  or  the  contralateral
organs and was irrespective of the stage of the
estrous cycle. This difference between species
may  be  explained  by  the  different  technique
adopted since the immunochemical detection of
the protein must be confirmed by a quantitative
analysis. Moreover, the level of the transcript
must be determined in order to assess whether
or  not  the  phase-independent  localization  of
PGRMC1  observed  in  this  study,  in  bovine
oviduct and uterus, is accompanied by a phase-
independent PGRMC1 transcript level. 
In the present study we did not observe differ-
ences  in  PGRMC1  localization  in  the  uterus
between  the  luteal  and  follicular  phases.
However, we do not exclude that these differ-
ences could arise during pregnancy. In fact, a
decrease  in  PGRMC1  has  been  observed  in
human  myometrium  during  term  or  preterm
labor,  where  PGRMC1  down-regulation  might
contribute to the functional withdrawal of prog-
esterone’s action and shift the balance to a state
of  increased  uterine  contractility.30 Moreover,
PGRMC1  was  described  in  the  human  and
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Figure  5.  Immunohistochemical  localization  of  PGRMC1  in  bovine  oviduct  and  uterus.
PGRMC1 is expressed in the different tracts of the oviduct, infundibulum (A), ampulla (B) and
isthmus (C) in luminal epithelium, in the muscle layers (ml) and in the vessels (arrowheads).
In the uterus PGRMC1 is localized in luminal (E) and glandular (F) epithelium, in the muscle
layers (ml) and in the endothelial cells (arrowheads). Note that the nuclear staining of epithe-
lial cells is intense both in oviduct and uterus. No immunoreactivity was seen in negative con-
trol where incubation with the primary antibody had been omitted(D). Final magnification,
200X; scale bar, 50 µm.[page 150] [European Journal of Histochemistry 2011; 55:e27]
mouse placenta and associated membranes with
the most abundant expression in smooth muscle
of the placental vasculature, villous capillaries
and the syncytiotrophoblast suggesting that this
protein functions in events important to early
pregnancy,  including  cellular  differentiation,
modulation of apoptosis and steroidogenesis.10
Therefore, the study of PGRMC1 localization and
expression during pregnancy in the cow would
be  of  particular  interest  since  dissimilarities
between species could be due to the different
involvement of the endometrium in the process
of placentation in these species. Rodents and
primates are characterized by an haemochorial
placenta while cows have a synepitheliochorial
placenta. Further studies are needed in order to
confirm this hypothesis.
In  conclusion,  the  present  immunohisto-
chemical study showed that PGRMC1 is locat-
ed  in  various  compartments  of  the  bovine
female reproductive organs. Despite some dif-
ference  in  PGRMC1  expression  have  been
reported in human and mouse, our data sug-
gest  that  with  the  exception  of  the  corpora
lutea, PGRMC1 localization does not seem to
be  differentially  regulated  during  different
stages of the estrous cycle. However, a quanti-
tative study must be conducted in order to clar-
ify  the  phase-independency  of  PGRMC1
expression in this species.
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